Report Overview

An increasing focus on the diagnosis, treatment, and management of the rising prevalence of infectious and chronic diseases, and the growing adoption of innovative IVD technologies are expected to boost the growth of Nigeria In-Vitro Diagnostics (IVD) Market during the forecast period between 2025 and 2031.

Nigeria In-Vitro Diagnostics (IVD) Market - Industry Trends & Forecast Report, 2031

Nigeria In-Vitro Diagnostics (IVD) Market size was estimated to be worth USD 37.12 million in 2024. During the forecast period between 2024 and 2031, Nigeria In-Vitro Diagnostics (IVD) Market size is projected to grow at a CAGR of 3.74%, reaching a value of USD 48.01 million by 2031. Major growth factors for Nigeria In-Vitro Diagnostics (IVD) Market include the rising prevalence of various communicable and non-communicable diseases and the increasing geriatric population. As a result, the number of point-of-care tests is growing along with the increasing adoption of automation in laboratories and automated instruments, which is anticipated to present lucrative growth opportunities for Nigeria In-Vitro Diagnostics (IVD) Market over the forecast period.

Source: BlueWeave Consulting

In-Vitro Diagnostics (IVD) – Overview

In-vitro diagnostics (IVD) refers to tests conducted on samples, such as blood or tissue that have been extracted from the human body. These diagnostics are used to detect diseases or other health conditions, monitor a person's overall health, and assist in treating illnesses. In precision medicine, IVDs are also used to identify patients likely to benefit from particular treatments or therapies. Next-generation sequencing tests are an example of an IVD that screens an individual's DNA to detect genomic variations. IVDs are critical tools for everyday medical practice and emergencies, and numerous treatment decisions are based on their results.

Nigeria In-Vitro Diagnostics (IVD) Market

Growth Drivers

Rising Prevalence of Chronic and Infectious Diseases

The growing geriatric population and rising rate of prevalence of chronic and infectious diseases in Nigeria have directly influenced the demand for in-vitro diagnostics (IVD) across the country. With the rapidly aging population, the prevalence of age-associated diseases, such as high blood cholesterol levels, stroke, and diabetes, is projected to rise in the coming years. Hence, the growing elderly population and the rising prevalence of chronic and infectious diseases across demographic segments are driving Nigeria In-Vitro Diagnostics (IVD) Market.

Challenges

Complex Regulations and High Cost

A major challenge for the growth of Nigeria In-Vitro (IVD) Diagnostics Market is the complex regulatory framework for approval. Inadequate reimbursement is a major factor in slowing the market growth. High cost of advanced diagnostics makes a large section of the low-income economy, like Nigeria, avoiding IVD tests altogether. The limited number of trained laboratory technicians further affects Nigeria IVD Market.

Impact of Escalating Geopolitical Tensions on Nigeria In-Vitro Diagnostics (IVD) Market

Intensifying geopolitical, trade, and tariff tensions among countries across the major regions could disrupt the growth of Nigeria In-Vitro Diagnostics (IVD) Market. For instance, China is a major exporter of medical diagnostic test instruments. Furthermore, geopolitical tensions cause supply chain disruption, which hinders the accessibility to healthcare products as well as eventually lead to surge in prices, which may negatively impact the growth Nigeria In-Vitro Diagnostics (IVD) Market.

Nigeria In-Vitro Diagnostics (IVD) Market

Segmental Coverage

Nigeria In-Vitro Diagnostics (IVD) Market – By Product & Services

Nigeria In-Vitro Diagnostics (IVD) Market by products & services is divided into reagents & kits, instruments, and software & services segments. The reagents & kits segment accounts for the largest market share of Nigeria In-Vitro Diagnostics (IVD) Market by products & services. The instrument segment is forecast to grow at a high rate during the period in analysis. Technological advancements and rising automation in the industry, along with an increasing demand for faster and more efficient diagnostic processes, are expected to drive the growth of the instrument segment during the forecast period.

Source: BlueWeave Consulting

Nigeria In-Vitro Diagnostics (IVD) Market – By Technique

Based on technique, Nigeria In-Vitro Diagnostics (IVD) Market is divided into molecular diagnostics, tissue diagnostics, clinical chemistry, immunodiagnostics, hematology, and other techniques segments. The molecular diagnostics segment holds the largest share in Nigeria In-Vitro Diagnostics (IVD) Market by technique. The growth of the market is mainly attributed to the rising adoption of rapid testing and point-of-care. Molecular diagnosis is used for various purposes, including disease diagnosis and monitoring, risk detection, and determining the best-suited therapy for a patient. The rising demand for precision medication is anticipated to fuel the demand for molecular diagnosis as well over the forecast period.

Nigeria In-Vitro Diagnostics (IVD) Market – By Application

On the basis of application, Nigeria In-Vitro Diagnostics (IVD) Market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. The infectious diseases segment accounts for the largest market share, owing to the rising prevalence of communicable diseases in Nigeria. This results in the launch of testing solutions specifically designed for testing infectious diseases, which drives market growth. In addition, the COVID-19 outbreak further proliferated market growth owing to the use of assays for the detection of SARS-CoV-2.

Nigeria In-Vitro Diagnostics (IVD) Market – End User

By end user, Nigeria In-Vitro Diagnostics (IVD) Market is divided into Standalone Laboratories, Hospitals, Academic & Medical Schools, Point of Care (PoC), and other end users segments. The increasing number of hospital facilities and their dependence on IVD for diagnosis and treatment decisions fuel the demand for in-vitro diagnostic (IVD) tests. The high rate of in-patient and out-patient treatment in hospitals due to the presence of advanced diagnostic setups further contributes to the segment growth. Hence, the hospital segment dominates Nigeria In-Vitro Diagnostics (IVD) Market by end user. Meanwhile, the point-of-care (PoC) segment is also expected to grow at a high rate over the forecast period. Other major end user segments in Nigeria In-Vitro Diagnostics (IVD) Market include standalone laboratories, and academic & medical schools.

Competitive Landscape

Nigeria In-Vitro Diagnostics (IVD) Market is intensely competitive, as a number of companies are competing to gain a significant market share. Key players in the market include Abbott Laboratories, Afrigold Medicure, Becton, Dickinson and Company, bioMérieux, Danaher Corporation, Me Cure Healthcare, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Union Diagnostics and Clinical Service PLC. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In May 2025, Codix Pharma Ltd launched Codix Bio Ltd Manufacturing Facility, an IVD manufacturing plant in Sagamu, Nigeria. The manufacturing facility is expected to reduce the country's dependence on imported diagnostic kits and reagents, especially for malaria and HIV.

Scope of the Report

By Product and Services

• Reagents & Kits

• Instruments

• Software & Services

By Technique

• Molecular Diagnostics

• Tissue Diagnostics

• Clinical Chemistry

• Immunodiagnostics

• Hematology

• Others

By Application

• Infectious Diseases

• Cancer

• Cardiac Diseases

• Immune System Disorders

• Nephrological Diseases

• Gastrointestinal Diseases

• Others

By End User

• Standalone Laboratories

• Hospitals

• Academic & Medical Schools

• Point of Care

• Others